U.S., May 1 -- ClinicalTrials.gov registry received information related to the study (NCT07560124) titled 'A Study of AK138D1 Alone or in Combination With Ivonescimab in Advanced Breast Cancer' on April 24.
Brief Summary: The goal of this clinical trial is to evaluate the safety, tolerability, and efficacy of AK138D1 as monotherapy or in combination with ivonescimab in patients with advanced breast cancer.
Participants will receive study treatment with AK138D1 alone or in combination with ivonescimab, undergo safety assessments and tumor evaluations, and be followed for treatment tolerability, antitumor activity, and clinical outcomes.
Study Start Date: June 06
Study Type: INTERVENTIONAL
Condition:
Breast Cancer
Intervention:
DRUG: ...